Edwards Lifesciences (EW) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $784.8 million.
- Edwards Lifesciences' Other Non-Current Assets rose 1482.08% to $784.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $784.8 million, marking a year-over-year increase of 1482.08%. This contributed to the annual value of $721.6 million for FY2024, which is 5578.58% up from last year.
- Per Edwards Lifesciences' latest filing, its Other Non-Current Assets stood at $784.8 million for Q3 2025, which was up 1482.08% from $743.0 million recorded in Q2 2025.
- Over the past 5 years, Edwards Lifesciences' Other Non-Current Assets peaked at $789.8 million during Q2 2024, and registered a low of $105.3 million during Q2 2021.
- For the 5-year period, Edwards Lifesciences' Other Non-Current Assets averaged around $437.1 million, with its median value being $412.1 million (2023).
- In the last 5 years, Edwards Lifesciences' Other Non-Current Assets crashed by 3153.45% in 2021 and then skyrocketed by 16994.58% in 2022.
- Over the past 5 years, Edwards Lifesciences' Other Non-Current Assets (Quarter) stood at $110.8 million in 2021, then skyrocketed by 169.95% to $299.1 million in 2022, then soared by 54.86% to $463.2 million in 2023, then skyrocketed by 55.79% to $721.6 million in 2024, then grew by 8.76% to $784.8 million in 2025.
- Its Other Non-Current Assets was $784.8 million in Q3 2025, compared to $743.0 million in Q2 2025 and $742.7 million in Q1 2025.